Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
36,991,329
-
Shares change
-
+9,488,856
-
Total reported value, excl. options
-
$46,608,472
-
Value change
-
+$10,727,439
-
Put/Call ratio
-
104%
-
Number of buys
-
32
-
Number of sells
-
-23
-
Price
-
$1.26
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2023
77 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q1 2023.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36,991,329 shares
.
Largest 10 shareholders include BVF INC/IL (9,544,262 shares), Artal Group S.A. (8,589,064 shares), NEA Management Company, LLC (4,764,440 shares), Octagon Capital Advisors LP (3,000,000 shares), VANGUARD GROUP INC (2,460,833 shares), AXA S.A. (1,609,061 shares), ACADIAN ASSET MANAGEMENT LLC (1,401,653 shares), GOLDMAN SACHS GROUP INC (901,891 shares), BlackRock Inc. (648,915 shares), and TWO SIGMA ADVISERS, LP (594,500 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.